HIGHLIGHTS
- who: Michal Vechoropoulos and colleagues from the The Institute of Endocrinology, Metabolism, and Hypertension, Tel Aviv-Sourasky Medical Center, The Sackler Faculty of Medicine, Tel Aviv University, Weizmann Street, Tel Aviv, Israel have published the research: The Proatherogenic Effect of Chronic Nitric Oxide Synthesis Inhibition in ApoE-Null Mice Is Dependent on the Presence of PPAR š¯›¼, in the Journal: (JOURNAL) of 22/01/2014
- what: In the current report the authors show this to be the case, and the authors also point at two main culprits in the PPARš¯›¼-dependent proatherogenic effect of eNOS inhibition . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.